EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H14N2O4 |
| Net Charge | 0 |
| Average Mass | 310.309 |
| Monoisotopic Mass | 310.09536 |
| SMILES | CN1C(=O)c2ccccc2NC(=O)[C@@]12O[C@H]2c1cccc(O)c1 |
| InChI | InChI=1S/C17H14N2O4/c1-19-15(21)12-7-2-3-8-13(12)18-16(22)17(19)14(23-17)10-5-4-6-11(20)9-10/h2-9,14,20H,1H3,(H,18,22)/t14-,17+/m0/s1 |
| InChIKey | BDDNYDPRCCDQQJ-WMLDXEAASA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Penicillium sclerotiorum (ncbitaxon:69788) | - | PubMed (24773150) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (+)-cyclopenol (CHEBI:207057) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (3R,3'S)-3'-(3-hydroxyphenyl)-4-methylspiro[1H-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione |
| Manual Xrefs | Databases |
|---|---|
| 30656810 | ChemSpider |